-
Signature
-
/s /Allan Reine, M.D., Attorney-in-Fact
-
Stock symbol
-
FHTX
-
Transactions as of
-
Aug 31, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
9/2/2022, 08:07 AM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
FHTX |
Common Stock |
|
|
|
|
|
295K |
Aug 31, 2022 |
Direct |
|
| holding |
FHTX |
Common Stock |
|
|
|
|
|
3.33M |
Aug 31, 2022 |
See Footnote |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
FHTX |
Stock Options (Right to buy) |
|
|
|
|
|
16K |
Aug 31, 2022 |
Common Stock |
16K |
$13.81 |
Direct |
|
| holding |
FHTX |
Stock Options (Right to buy) |
|
|
|
|
|
12.5K |
Aug 31, 2022 |
Common Stock |
12.5K |
$9.40 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Cigall Kadoch is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses: